0
Skip to Content
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Budget Docs
Contact
Alliance Archives
Join Us
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Budget Docs
Contact
Alliance Archives
Join Us
Folder: About
Back
About Us
Leadership
Folder: Members
Back
Join Us
List of Members
Who can Become a Member
Budget Docs
Contact
Alliance Archives
Join Us
Analysis and Commentary Guest User 6/19/20 Analysis and Commentary Guest User 6/19/20

How Well Is This Year's Appropriation Process Working?

Read More
Analysis and Commentary Guest User 6/12/20 Analysis and Commentary Guest User 6/12/20

"I Believe in FDA Exceptionalism and You Should Too"

Read More
Advocacy at a Glance Guest User 6/12/20 Advocacy at a Glance Guest User 6/12/20

House and Senate Set Schedule for FY 21 Appropriations Mark-Ups

Read More
Analysis and Commentary Guest User 6/5/20 Analysis and Commentary Guest User 6/5/20

Pandemic Actions Taken ... and Lessons Learned

Read More
Advocacy at a Glance Guest User 6/5/20 Advocacy at a Glance Guest User 6/5/20

Commissioner Hahn’s Address to the Alliance Gains Wide Attention

Read More
Advocacy at a Glance Guest User 5/22/20 Advocacy at a Glance Guest User 5/22/20

Hurry Up and Slow Down (Once Again)

Read More
Advocacy at a Glance Guest User 5/22/20 Advocacy at a Glance Guest User 5/22/20

Procedural Path Cleared for House Mark-up Appropriations; Impediments Remain

Read More
Analysis and Commentary Guest User 5/15/20 Analysis and Commentary Guest User 5/15/20

How H.R. 6800 Might Impact the FDA

Read More
Advocacy at a Glance Guest User 5/15/20 Advocacy at a Glance Guest User 5/15/20

Virtual Mark-ups: Prerequisite for Movement of Appropriations Bills

Read More
Analysis and Commentary Guest User 5/8/20 Analysis and Commentary Guest User 5/8/20

The Frieden Health Defense Funding Proposition

Read More
Advocacy at a Glance Guest User 5/8/20 Advocacy at a Glance Guest User 5/8/20

House and Senate Appropriations Committees Still Committed, Off to a Slow Start

Read More
Analysis and Commentary Guest User 5/1/20 Analysis and Commentary Guest User 5/1/20

No Need for a Crystal Ball in Some Scenarios

Read More
Advocacy at a Glance Guest User 5/1/20 Advocacy at a Glance Guest User 5/1/20

Senate Returns May 4; Appropriations Activities Planned and Rules for Remote Voting Are Prominent

Read More
Analysis and Commentary Guest User 4/24/20 Analysis and Commentary Guest User 4/24/20

How Can Congress Agree to Appropriations for FY 21?

Read More
Advocacy at a Glance Guest User 4/24/20 Advocacy at a Glance Guest User 4/24/20

Appropriations Committees Still Have No Schedule; House Rules Do Not Permit Remote Mark-ups

Read More
Analysis and Commentary Guest User 4/17/20 Analysis and Commentary Guest User 4/17/20

The COVID-19 Pandemic and Maintenance of a Continued Safe Food Supply

Read More
Advocacy at a Glance Guest User 4/17/20 Advocacy at a Glance Guest User 4/17/20

Congress Out Until at Least May 4; Not Clear How Work Will Be Done

Read More
Analysis and Commentary Guest User 4/3/20 Analysis and Commentary Guest User 4/3/20

Advocating for a Responsibility-based "Ask"

Read More
Advocacy at a Glance Guest User 4/3/20 Advocacy at a Glance Guest User 4/3/20

Alliance Submits House/Senate Testimony on FY 21 Appropriations for FDA

Read More
Analysis and Commentary Guest User 3/27/20 Analysis and Commentary Guest User 3/27/20

Coronavirus, Pandemic Preparedness, and Beyond

Read More
Newer Posts
Older Posts

The Alliance for a Stronger FDA | 918 14th Street, SE, Apt 1 Washington, DC 20003 | cartier@strengthenfda.org | LinkedIn

The Alliance for a Stronger FDA is an independent, not-for-profit 501(c)(4) corporation registered in the state of Maryland. It is not affiliated with the FDA and current FDA employees can not become members of the Alliance. For information from the FDA, please click here. Copyright 2025, Alliance for a Stronger FDA.